1. Home
  2. NOMD vs HRMY Comparison

NOMD vs HRMY Comparison

Compare NOMD & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

N/A

Current Price

$10.35

Market Cap

1.8B

ML Signal

N/A

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$28.78

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NOMD
HRMY
Founded
2014
2017
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
NOMD
HRMY
Price
$10.35
$28.78
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$14.25
$46.70
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
01-01-0001
05-18-2026
Dividend Yield
6.69%
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
N/A
$19.87
Revenue Next Year
$0.36
$12.49
P/E Ratio
$8.38
$10.57
Revenue Growth
N/A
21.51
52 Week Low
$9.82
$25.52
52 Week High
$20.22
$40.87

Technical Indicators

Market Signals
Indicator
NOMD
HRMY
Relative Strength Index (RSI) 26.20 34.40
Support Level N/A $27.66
Resistance Level $12.36 $37.38
Average True Range (ATR) 0.35 1.59
MACD -0.18 0.08
Stochastic Oscillator 15.80 35.66

Price Performance

Historical Comparison
NOMD
HRMY

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: